Podcasts about Rheumatology

They discuss how they became Rheum Champions, their personal journeys with conditions like rheumatoid arthritis, lupus, PCOS, and more, and the importance of community and support. The episode also highlights significant takeaways from the meeting, including research updates, the passion of the researchers, and the heartwarming sense of community.  This podcast serves as a powerful reminder of how important it is to integrate the patient voice into rheumatology research.   *This episode was originally recorded for the My Spoonie Sisters podcast. Episode at a glance:00:00 Welcome to the Rheum Champions Tell All01:59 Introducing the Rheum Champions03:55 Sharing Our Stories: The Journey to Advocacy07:13 The Impact of Community and Support10:55 Becoming a Rheum Champion16:09 Highlights from the 2025 Investigators Meeting24:52 Final Thoughts and How to Get InvolvedMedical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist. Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA) - doi.org/10.3899/jrheum.2024-1303 Antimicrobial Use and Serious Infections Among Patients With Psoriatic Arthritis After Initiating Tumor Necrosis Factor Inhibitors: A Nationwide Matched Cohort Study - doi.org/10.3899/jrheum.2025-0029 Identifying the State of Mental Health Care in Canadian Adults With Systemic Lupus Erythematosus - doi.org/10.3899/jrheum.2025-0089 Evaluation of a Pediatric-Adult Dyad Care Model for Transitioning Youth With Childhood-Onset Systemic Lupus Erythematosus - doi.org/10.3899/jrheum.2025-0046 Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample - doi.org/10.3899/jrheum.2025-0048

Stay plugged into the conversations, discoveries, and breakthroughs moving rheumatology forward. Real updates. Real context. For clinicians who never stop learning.

In today's episode of the My DPC Story Podcast, host Dr. Maryal Concepcion interviews Dr. Isabel Amigues, the first Direct Specialty Care rheumatologist in Colorado and founder of Unabridged MD in Denver. Dr. Amigues shares her inspiring journey through training in both France and the US, and how surviving stage 4 metastatic breast cancer transformed her medical approach. Blending Western medicine with holistic healing techniques like meditation, visualization, and energy work, she delivers personalized rheumatology care outside the constraints of insurance models. The episode dives deep into her rapid practice growth, patient-centered philosophy, and the advantages of direct specialty care for chronic and autoimmune diseases. Listeners gain valuable insight on patient advocacy, overcoming healthcare burnout, medication access, and building a thriving DPC clinic. Connect with Dr. Amigues for expert rheumatologic care and learn how direct specialty care empowers both physicians and patients. Keywords: direct primary care, direct specialty care, rheumatology, Unabridged MD, Dr. Isabel Amigues, Denver, autoimmune disease, holistic medicine, fee-for-service alternative, physician burnout, patient advocacy.Save $100 on your Hint Summit 2026 ticket through October 31st and join the chorus of direct care leaders shaping tomorrow. Register HERE for the Physician Attendees ONLY RiseUP Summit brought to you by FlexMed Staff & My DPC Story! Get your DPC Resources HERE at mydpcstory.com!Support the showBe A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

In this episode, we sit down with Dr. Kristin to discuss her session at ACR Convergence on taking a personalized approach to pulmonary hypertension in connective tissue diseases. She shares why now is the critical moment for this shift and how “personalized” care extends beyond biomarkers and imaging to encompass clinical nuances, patient-reported symptoms, and multidisciplinary collaboration. We explore the key challenges in detecting pulmonary hypertension early, the promise of emerging technologies like AI-assisted imaging and molecular diagnostics, and the subtle red flags clinicians should recognize in at-risk patients. Dr. Kristin also reflects on her unique dual training in rheumatology and pulmonology, the defining moments that shaped her career, and how mentorship continues to drive innovation and compassion in the care of patients with connective tissue lung disease. 

In this episode, we explore RheumCode, a groundbreaking new initiative from the American College of Rheumatology (ACR) designed to build a common digital language for rheumatology. RheumCode aims to ensure that data means the same thing wherever it lives—whether in an EHR, a clinic, or a registry—enabling systems to seamlessly communicate and make better use of the medical information already being documented. We discussed how RheumCode began, the collaboration behind its development, and its potential to transform the way clinicians practice; researchers study disease, and patients experience their care.  This episode was sponsored by Pfizer  

Guest: Gary S. Firestein, MD Despite advances in biologics, many patients with rheumatoid arthritis still experience persistent inflammation. However, cadherin-6 has recently been identified as a potential treatment target. Hear from Dr. Gary Firestein as he explains the discovery, function, and therapeutic potential of cadherin-6 in rheumatoid arthritis pathogenesis. Dr. Firestein is a Distinguished Professor of Medicine and the Senior Associate Vice Chancellor for Health Sciences at UC San Diego.

Guest: Gary S. Firestein, MD While cadherin-6 may not yet shift clinical practice in rheumatoid arthritis, its role as a surface-expressed, actionable target opens the door to rapid therapeutic development—particularly with existing antibodies already in clinical trials for urologic cancers. Dr. Gary Firestein discusses the potential for cadherin-6 to become a useful target across multiple diseases. Dr. Firestein is a Distinguished Professor of Medicine and the Senior Associate Vice Chancellor for Health Sciences at UC San Diego.

Dr. Edens debunks common misconceptions, such as vaccines causing autoimmune diseases or always triggering flares. She explains that while mild immune responses are normal, serious complications are extremely rare and the benefits far outweigh the risks. Dr Edens emphasizes that vaccines not only prevent infections but also certain cancers, making them an essential part of care for immunosuppressed patients. The discussion also explores vaccine timing with medications, the dangers of misinformation, and how to talk about vaccine hesitancy with empathy and evidence.Episode at a glance:Guest Expert: Dr. Cuoghi Edens, dual-trained adult and pediatric rheumatologist at the University of Chicago.Myth #1: “Natural is better than vaccines” — Debunked; vaccines dramatically reduce child and adult mortality from infectious diseases.Myth #2: “Vaccines cause autoimmune diseases” — Overwhelming evidence shows they do not.Myth #3: “Vaccines always cause flare-ups” — Possible but uncommon; most patients tolerate vaccines well, and disease prevention outweighs brief discomfort.Risk–Benefit Balance: Vaccines protect against infections and cancers (HPV, hepatitis B) that can worsen or complicate autoimmune diseases.Timing & Medications: ACR guidelines suggest coordination with treatments like rituximab and high-dose steroids, but partial protection is better than none.Health Literacy Tip: “Doing research” means reviewing credible scientific evidence—not social-media opinions or cherry-picked studies.Social Stigma: Addresses misinformation, polarization, and “anti-vax” rhetoric, highlighting the need for compassion and critical thinking.Trusted Resources: Children's Hospital of Philadelphia vaccine education site and American College of Rheumatology guidelines.Key Takeaway: Vaccines are safe, vital, and empowering tools for people with autoimmune diseases.Medical disclaimer: All content found on Arthritis Life public channels (including Rheumer Has It) was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! Full Episode Show Notes:Go to the episode page on the Arthritis Life website for full details including a transcript and video!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Carole Keim welcomes Clinical Assistant Professor of Pediatric Rheumatology Dr. Cristina Saez, MD, to The Baby Manual to discuss what rheumatology is and how pediatric rheumatology works. She studies and has training in autoimmune diseases, specifically ones affecting bones, muscles, joints, or multiple organ systems,  in children. Dr. Saez tells Dr. Keim that though she sees children for different things, the most common is joint pain. Juvenile arthritis is likely the most common rheumatologic diagnosis seen in her clinic. Cristina details how joint pain presents in children and the method of assessment used in diagnosis. She also treats a lot of recurrent fevers and tells Carole how fevers can present in diseases that affect the immune system, which is what she works to assess. Practical information on how to identify joint pain, what grade of fever should prompt medical intervention, and the types of medication used in treatment are all explained by Dr. Saez in this insightful episode. Dr. Cristina Saez, MD:Dr. Cristina Saez is the Clinical Assistant Professor of Pediatric Rheumatology at Stanford Medicine. She graduated from Rice University with a BA in Kinesiology with a focus on Health Sciences in 2015. After graduation, she started medical school at Baylor College of Medicine. While there, she was an active member of the Pediatric Student Association and participated in the Medical Ethics Track. Outside of class, she enjoyed mentoring younger students through the Anatomy Buddies tutoring program and the Peer Resource Network program. She still kept in touch with the Kinesiology Department and even helped teach undergraduate students in the gross anatomy course. During her later years, she helped develop a protocol within the Pediatric Rheumatology department at Texas Children's Hospital to help adolescent patients prepare for the transition from pediatric to adult care.__ Resources discussed in this episode:The Holistic Mamas Handbook is available on AmazonThe Baby Manual is also available on Amazon__Contact Dr. Carole Keim, MDlinktree | tiktok | Instagram Contact Dr. Cristina Saez, MDStanford Medicine Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Welcome to ACR Convergence 2025 in Chicago! Here, Dr. Hausmann delivers a quick update on what our podcasts will cover while the meeting is in session. Don't forget to tune in to ACR on Air and ACR Journals on Air each morning, starting this Saturday, to catch up on the latest in Rheumatology

Description: Listen as NPF Medical Board Members, dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman discuss the connections between psoriasis and psoriatic arthritis, from cytokines to triggers, current and future treatments.   Join moderator Alan Simmons as he gains insights on what connects psoriasis and psoriatic arthritis with leading experts in psoriatic disease and NPF Medical Board members, dermatologist Dr. Robert Kalb with Buffalo Medical Group Dermatology, and rheumatologist Dr. Sergio Schwartzman from Schwartzman Rheumatology, as they discuss the known drivers of psoriasis and psoriatic arthritis, common triggers, benefits of targeted treatments, remission of disease, and upcoming treatment trends. The intent of this episode is to identify potential connections between psoriasis and psoriatic arthritis, and how targeted treatments have changed the outlook for management of psoriatic disease. This episode is sponsored by Novartis. Timestamps: (0:41) Intro to Psoriasis Uncovered and guest welcome dermatologist Dr. Robert Kalb and rheumatologist Dr. Sergio Schwartzman who are both involved in clinical care and research of psoriasis and psoriatic arthritis.  (1:15) Current known pro-inflammatory cytokines and cells found in psoriasis and psoriatic arthritis.   (5:33) Types of psoriasis that may lead to a higher risk of developing psoriatic arthritis. (9:33) Common triggers for psoriasis and psoriatic arthritis that could cause flares of the disease. (12:59) Key factors that are considered when choosing a treatment plan for any individual with psoriatic arthritis and psoriasis. (18:04) What treatment remission means for psoriasis. (19:36) Use of minimal disease activity (MDA) in psoriatic arthritis and what it means. (22:14) How a better understanding of the disease has led to more effective treatment choices and what choices are used by Dr. Kalb and Dr. Schwartzman for the management of psoriasis and psoriatic arthritis. (28:39) New developments in treatment and research in psoriatic arthritis and psoriasis. (36:01) Given treatment advancements it's a wonderful time to treat psoriatic disease. 3 Key Takeaways: ·       Cytokines are chemicals in the body that moderate various processes. In psoriasis and psoriatic arthritis,  an unknown trigger stimulates some cells to overproduce pro-inflammatory cytokines such as TNF-alpha, IL-17 or IL-23 leading to the development of skin and joint disease.  ·       Treating psoriasis and psoriatic arthritis helps move the body towards normalizing the over reactive immune system especially with more targeted treatments that safely and effectively block specific cytokines without affecting other organ systems.  ·       Given advancements in targeted treatments the goal is to reach and maintain remission of psoriatic disease. Guest Bios:   Leading dermatologist Robert Kalb, M.D. is the Chair of the Buffalo Medical Group Dermatology Department and the Director of the Buffalo Medical Group Phototherapy Center, one of the leading centers for psoriasis care in Western New York. He is also a Clinical Professor of Dermatology at the State University of New York at Buffalo School of Medicine and Biomedical Sciences (SUNY Buffalo), as well as an Adjunct Professor of Dermatology at the Perelman School of Medicine at the University of Pennsylvania where he plays a significant role in medical education, mentoring both medical students and dermatology residents. Dr. Kalb has extensive experience managing psoriasis, atopic dermatitis, and other inflammatory skin diseases. He has authored 70+ publications and is actively involved in clinical research, particularly focused on new treatment options for psoriasis. He is a member of the NPF Medical Board, American Academy of Dermatology, and is a member of the International Psoriasis Council.  Sergio Schwartzman, MD, is a world-renowned rheumatologist based in New York City who brings almost 40 years of experience and personalized clinical care for those who have psoriatic disease. Along with being in private practice at Schwartzman Rheumatology, Dr. Schwartzman is a Clinical Associate Professor of Medicine at Weill Cornell Medical College of Cornell University, the New York-Presbyterian Hospital, and the Hospital for Special Surgery in New York City where he has played a role in educating medical students, residents, fellows, and peers in rheumatology. Additionally, Dr. Schwartzman is the emeritus Franchellie M. Cadwell Clinical Associate Professor at the Hospital for Special Surgery. Dr. Schwartzman's current research interests include psoriatic arthritis, the spondyloarthritis group of diseases, ankylosing spondylitis, rheumatoid arthritis, as well as defining and treating autoimmune diseases of the eye. He has authored, co-authored, and edited over 150 papers, abstracts, books and book chapters on topics including psoriatic arthritis, ankylosing spondylitis, axial spondylarthritis, rheumatoid arthritis, lupus, autoimmune eye disorders, and other rheumatological and autoimmune conditions. He is a member of the NPF Medical Board. He is also a member of the American College of Rheumatology, the Association for Research in Vision and Ophthalmology, the Spondyloarthritis Research and Treatment Network (SPARTAN), the American Uveitis Society, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Resources: Ø  “Redefining Remission. A new definition for patients, providers, and payers.” Advance Online, National Psoriasis Foundation. S. Schlosser. July 14, 2025.   Ø  Treatment and Management of Psoriasis     Ø  Treatment and Management of Psoriatic Arthritis  

Host: Ryan Quigley New research presented at the 2025 American College of Rheumatology Convergence highlights a critical link between adverse childhood experiences and mental health outcomes in adolescents with childhood-onset systemic lupus erythematosus (cSLE). In this AudioAbstract, Ryan Quigley explores the findings, the implications for trauma-informed care, and the need to assess psychosocial history in managing cSLE.

Together, they unpack common myths surrounding food and autoimmune conditions and share practical, real-life strategies for self-management. It's a conversation packed with practical advice and empowering insights for anyone looking to make nutrition more manageable while living with an autoimmune condition.Episode at a glance:Common misconceptions about diet and autoimmune diseases: Cheryl and Dr. Singla discuss common myths about diet and nutrition for autoimmune diseases.How Dr. Singla adapts her kitchen for comfort and efficiency: Organizing items to avoid reaching or bending, using pre-chopped ingredients to reduce strain, utilizing assistive kitchen tools (many available on Amazon)Creative, real-life kitchen strategies: Wearing weightlifting gloves for cutting tough vegetables, prepping water ahead of time to avoid lifting heavy potsMedical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Did you know that the healthcare industry has a bigger climate change footprint than the airline industry? In this episode of 'Around the Rheum,' hosts Dr. Daniel Ennis and Dr. Janet Pope join in conversation about how rheumatologists can help fight global warming with Dr. Stephanie Tom, the Rheumatology Division Head at Trillium Health Partners in Mississauga, ON and Vice President of the Canadian Rheumatology Association (CRA).

Guest: Eric Ruderman, MD Combined dermatology–rheumatology clinics are transforming psoriatic disease care by streamlining communication, reducing patient burden, and enabling more targeted, effective treatments. To learn more about how these clinks work and why they matter for patients with psoriatic disease, tune in to hear from Dr. Eric Ruderman, Professor of Medicine and the Associate Chief of Clinical Affairs for the Division of Rheumatology at Northwestern University Feinberg School of Medicine.

In this episode, Dr. Shaun Jackson uses a compelling patient case to illuminate the complex mechanisms of immune tolerance and autoimmunity. He explains how B cells learn to avoid targeting the body's own tissues through central and peripheral tolerance—and how these safeguards can fail. The discussion covers the roles of germinal centers, T cells, and rare genetic disorders in shaping immune regulation, with Alport's syndrome and post-transplant Goodpasture's disease serving as striking examples. Dr. Jackson also reflects on emerging directions in autoimmune research and shares his journey from medical training in South Africa to leading a research program in Seattle, offering valuable insights for future physician-scientists. 

The story of rheumatoid factor could be a 10 minute episode, but in this episode, we dig deep into the history of the lab techniques leading up to this discovery…that happened twice.  ·        Intro 0:04 ·        Rheumatoid factor quick background and history 00:22 ·        Rheumatology blood tests 2:47 ·        What is Rheumatoid factor? 3:39 ·        Spiderman and latex agglutination: Testing for rheumatoid factor 4:49 ·         4:54 ·        The double discovery of rheumatoid factor 7:52 ·        Putting agglutination on the medical map in 1896 10:03 ·        Pop Quiz! 11:04 ·        Serotherapy 13:00 ·        When did we start using agglutination for testing? 14:07 ·        First discovery of blood groups 14:44 ·        The complement fixation test 17:12 ·        Testing for syphilis with complement fixation and agglutination 20:53 ·        The first discovery of rheumatoid factor 24:02 ·        We forget about rheumatoid factor 27:48 ·        Rediscovering rheumatoid factor 28:20 ·        Analytical ultracentrifugation 32:55 ·        What rheumatoid factor is used for 35:50 ·        Thanks for listening 38:09   We'd love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum. References: Assadian O et al. Wien Klin Wochenschr. 2010;doi:10.1007/s00508-009-1297-1 Edelman GM, et al. J Exp Med. 1958;doi:10.1084/jem.108.1.105 Franklin EC, et al. J Exp Med. 1957;doi:10.1084/jem.105.5.425 Fraser KJ. Semin Arthritis Rheum. 1988;doi:10.1016/0049-0172(88)90035-2 Jonsson R. Ann Rheum Dis. 2020;doi:10.1136/annrheumdis-2019-216822 Mohd Noor NH, et al. Cureus. 2024;doi:10.7759/cureus.68903 Tan EM, et al. J Exp Med. 2016;doi:10.1084/jem.20160792 Disclosures: Brown reports no relevant financial disclosures.

In this Anxiety Chick's life update episode , Taylor shares the appointment that changed everything: confirmed Hashimoto's thyroiditis and rheumatoid arthritis after years of putting off a positive ANA workup. She opens up about confusing symptoms she'd chalked up to anxiety, why finally seeing a great rheumatologist mattered, and what treatment decisions might look like from here. Alison checks in on her own health journey…follow-up imaging, perimenopause shifts, colonoscopy planning and the very real stress of waiting for results. Together, the Chicks talk about advocating for yourself, finding doctors who listen, using your insurance (PPOs!) strategically, and balancing nervous-system care with medical care. What We Cover Taylor's diagnosis: Hashimoto's + rheumatoid arthritis—what that means and why it's a relief and a lot to process Autoimmune 101: ANA, thyroid antibodies (TPO), flares, allostatic load, and why symptoms can mimic anxiety Next steps: Rheumatology vs. endocrinology, why early treatment can prevent progression, and building a plan When anxiety overlaps with illness: differentiating flares from fear, and why self-gaslighting is easy to do Self-advocacy: symptom logging, asking for an expanded thyroid panel, and the reality that a positive ANA can occur in healthy people Finding the right doctor: why crowdsourced local Facebook groups can beat star ratings, and how to use your PPO without referrals Alison's update: non-invasive imaging follow-up (results pending), perimenopause changes, colonoscopy prep basics, and pacing life when you're overstimulated Nervous system care: stress, sleep, and small tools that help while you wait for answers (including Alison's mention of the Restore Patch) Don't forget to rate and review The Chicks!

Description: What role does osteopathy play in sports injury rehab? And how does it differ between an office worker and an athlete? Sandy Phanor answers these questions, as well as explaining the benefits of good patient education in preventing repeat injuries. Timestamps: 01:19 – Sports people 03:18 – Balancing recovery 04:30 – Office versus athletics 05:29 – Interesting case 06:51 – Patient education

Description: In the final episode, Sandy Phanor delves into how her background in law helps her to maintain her confidentiality and professionalism in the clinic. She also looks towards the future, discussing technological advancements and the future of holistic care. Timestamps: 01:14 – Law influence 02:15 – Osteopathy evolution 03:26 – Personalised plans 05:19 – Future technologies 7:00 – Holistic future

In this week's episode, we dive into the ins and outs of the rheumatology musculoskeletal ultrasound certification process—what it takes to log 150 scans, meet CME requirements, and ultimately sit for the exam. We're joined by Dr. Liudmila Kastsianok, who shares her insights on how ultrasound is reshaping clinical practice, from enhancing diagnostic accuracy to opening new avenues in research. We also explore how incorporating ultrasound into routine care can deepen the physician-patient relationship and improve communication. Finally, Dr. Kastsianok offers her perspective on where the field is headed and why ultrasound is becoming an essential skill for the next generation of rheumatologists. 

Event Objectives:Identify common referrals in pediatric rheumatology and utilize resources available for guidance.Apply evidence-based approach to the initial evaluation of patients presenting with musculoskeletal complaints.Differentiate clinical features suggestive of inflammatory versus non-inflammatory etiology of symptoms in patients presenting with musculoskeletal complaints.Claim CME Credit Here!

In this rapid-fire episode, Sandy Phanor answers quick questions about her craft, discussing misconceptions about osteopathy, common conditions such as back pain, common causes of conditions, such as slouching, and how she enjoys treating spinal issues the most.

Sandy Phanor reflects on her experiences in the clinic and explains how she harnesses the power of emotional connection with her patients, who now actively seek osteopathic appointments. Additionally, she explains her internal flow chart to assess patients. and how she ensures she uses the right technique in each situation. Timestamps: 01:16 – Emotional connection 03:18 – Emotional manifestations 05:59 – Which technique? 08:28 – Lifestyle effects 11:00 – Patient relationships

Dr. Jack Cush reviews the news, journal reports and important associations in rheumatology from the past week on RheumNow.com.

Send us a textIn this episode of the Fit Rx Health & Wellness Podcast, I sit down with Dr. Sehreen Mumtaz, MD, founder of Remission Rheumatology.  Dr. Mumtaz is a board-certified rheumatologist who is breaking new ground by offering a direct care membership model in a specialty field—something rarely seen outside of primary care.We talk about her journey in medicine, what led her to step away from the traditional insurance-based system, and why she believes direct specialty care can transform access and outcomes for patients dealing with complex autoimmune and rheumatologic conditions. Dr. Mumtaz shares the challenges and opportunities of building her practice, how patients benefit from more time, transparency, and affordability, and why she is passionate about pioneering this innovative approach to specialty care.If you've ever wondered what direct care could look like beyond primary care—or you're curious about how specialists can embrace new models to better serve patients—this is an inspiring and eye-opening conversation you won't want to miss.you can find her clinic at:www.remissionrheum.com

Cheryl and Dani dig into the diagnosis saga, evolving RA treatments, the role of acceptance, and why movement is essential to living well with rheumatic disease. For Dani, “movement” isn't only physical; it's emotional, spiritual, and educational. If you're newly diagnosed, this conversation is a powerful reminder to make every day count.Episode at a glance:Dani's Diagnosis Journey: Cheryl and Dani discuss Dani's journey to being diagnosed with rheumatoid arthritis.How Dani Rebuilt her Life: Dani recounts how she rebuilt her life after her diagnosis by slowly reintroducing weights and working through mental health challenges. The Importance of Movement: Cheryl and Dani discuss the importance of movement for those with arthritis, beyond physical movement.Make it Count for Dani: Dani and Cheryl delve into Dani's non-profit organization which provides support and hope for those living with RA.Medical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now!  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor David Kellner, an IGNITE-MSCR Fellow of the Division of Rheumatology, from UCLA Medical Centre, LA, USA, as they discuss his recent review ‘Effect of glucagon-like peptide 1 receptor agonists on patients with rheumatoid arthritis'.

Listen in as we discuss considerations, challenges, and strategies related to the use and switching of biosimilars in clinical practice.  You'll hear communication tips to address patient and prescriber concerns as well as operational considerations for integrating biosimilars into practice.  Special guests:Bharati Bhardwaja, PharmD, BCPS, LSSBBRheumatology Clinical Pharmacy SpecialistKaiser Permanente ColoradoMegan May, PharmD, BCOP, FHOPA, FAPOClinical Oncology Pharmacy SpecialistBaptist Health Lexington/Hamburg Cancer Care CenterYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityFor the purposes of disclosure, Dr. Megan May reports relevant financial relationships [lung cancer] with Amgen, AstraZeneca, Pharmacosmos (speakers bureau). The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in August 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Facts About BiosimilarsChart: Comparison of Insulins (United States)Chart: Biologics for Rheumatoid ArthritisChart: Biologics for Crohn's DiseaseUse code mt1025 at checkout for 10% off a new subscription.Send us a text****

In this episode, our guests Dr. Sabrina Hoa and Dr. Marie Hudson explore new insights into late-onset interstitial lung disease (ILD) in scleroderma. Using data from the Canadian Scleroderma Research Group, they discuss how ILD can still develop years after diagnosis, challenging traditional screening timelines. They cover key findings, clinical implications, treatment patterns, and the need for more inclusive trials. The conversation also touches on mentorship and what's next in scleroderma research. 

In this RCP Medicine podcast and BSR Talking Rheumatology podcast collaboration Dr Pip Watson and Dr Rik Patel discuss an interesting case of a patient presenting with headache to the acute take. Topics include tips on history and examination, an update on treatment including the use of tocilizumab and the role of fast-track pathways.  Pip is a Rheumatology Consultant in Manchester,  BSR Digital Learning Editor, and Talking Rheumatology host, Rick is a Rheumatology and Acute Medicine consultant in Manchester, working at one of the specialist centres for vasculitis.If you liked this check out related Talking Rheumatology spotlight episodes Episode 6 giant cell arteritisEpisode 14 polymyalgia rheumaticaBonus case non GCA headache  ResourcesNICE GCA guideline https://cks.nice.org.uk/topics/giant-cell-arteritis/BSR GCA guideline https://academic.oup.com/rheumatology/article-abstract/59/3/e1/5714024?redirectedFrom=fulltextGCAPS paper https://ard.bmj.com/content/83/Suppl_1/1100.2RCP Links Education Events Membership Improving care Policy and campaigns RCP Social Media Instagram LinkedIn Facebook X Bluesky Music: Episode 50 onward - Bensound.com Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas

Listen or watch along as we dive into updates on axial spondyloarthritis (axSpA) treatments and 'The 2025 British Society for Rheumatology guideline  for treatment of  axial Spondyloarthritis with biologic and targeted synthetic DMARDs'.In this episode, podcast host Mel Brooke, BIRDs Patient and Public Engagement Programme talks with Professor Raj Sengupta, Consultant rheumatologist  and Lead Consultant for Axial Spondyloarthritis at the RNHRD, RUH Bath about changes to axSpA treatments since our first series in 2020. Useful Links:BSR Guideline⁠National Axial Spondyloarthritis Society⁠Inhealthcare  Connect further with us:Have questions or thoughts about our information Podcast library?  Interested in joining BIRDs patient research panel? Email Mel at  ppe@birdbath.org.ukBe sure to subscribe, rate, and review the podcast to help us continue sharing information that matters!Thank you to all our sponsors for helping us to bring you information that supports you and helps to increase your knowledge of rheumatic diseases.Please visit the⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠BIRD website ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to sign up for news.

Listen or watch along as we dive into updates on axial spondyloarthritis (axSpA) treatments and 'The 2025 British Society for Rheumatology guideline  for treatment of  axial Spondyloarthritis with biologic and targeted synthetic DMARDs'.In this episode, podcast host Mel Brooke, BIRDs Patient and Public Engagement Programme talks with Professor Raj Sengupta, Consultant rheumatologist  and Lead Consultant for Axial Spondyloarthritis at the RNHRD, RUH Bath about changes to axSpA treatments since our first series in 2020. Useful Links:⁠BSR Guideline⁠⁠⁠National Axial Spondyloarthritis Society⁠⁠⁠Inhealthcare  ⁠Connect further with us:Have questions or thoughts about our information Podcast library?  Interested in joining BIRDs patient research panel? Email Mel at  ppe@birdbath.org.ukBe sure to subscribe, rate, and review the podcast to help us continue sharing information that matters!Thank you to all our sponsors for helping us to bring you information that supports you and helps to increase your knowledge of rheumatic diseases.Please visit the⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠BIRD website ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to sign up for news.

In this episode, we preview ACR Convergence 2025 in Chicago this October with Dr. Greg Gardner, Chair of the Annual Meeting Planning Committee (AMPC). We'll explore key topics like emerging therapies, AI in rheumatology, and highlights such as the Practice Innovation Summit, Ultrasound Course, and Fellows In Training (FiT) Program. Dr. Gardner also discusses highlights such as, CAR T-cell therapies, new non-renal lupus guidelines, a Live Journals Club focused on Big Data and why this year's meeting is earlier on the calendar. Tune in for a sneak peek at what's to come! 

Guest: Martin Cheatle, PhD Chronic pain is now recognized as a distinct disease that requires more than just a symptom-based approach. Lifestyle factors and psychological health are also important considerations for care, which is why a biopsychosocial approach can be key to better outcomes. Hear Dr. Martin Cheatle discuss the importance of this clinical mindset shift and practical strategies to help patients reduce suffering and improve function. Dr. Cheatle is an Associate Professor of Anesthesiology at the Hospital of the University of Pennsylvania and serves as Director of Behavioral Medicine at the PENN Pain Medicine Center and Director of Pain and Chemical Dependency Research at the Center for Studies of Addiction. He also gave a presentation on this topic at the 2025 Congress of Clinical Rheumatology West conference.

Melissa Christensen is a Physician Assistant at ima Healthcare specializing in treating rheumatic conditions including arthritis, tendinitis, lupus, gout and many others.See omnystudio.com/listener for privacy information.

Toxic chemicals sneak into our homes, food, and even water, and they're fueling the explosion of autoimmune disease. Autoimmune conditions are now among the fastest-growing health issues worldwide, and Dr. Aly Cohen explains exactly how toxins disrupt the immune system and what practical steps we can take to protect ourselves. In this episode, Dr. Cohen reveals the connection between our environment and the rise in autoimmune disorders. We talk about her new book Detoxify, the mechanisms by which chemicals misguide the immune system, and her 21-day plan to reduce daily exposures and support your body's natural defenses. If you're struggling with unexplained symptoms, autoimmune flares, or simply want to understand how your environment is shaping your health, this episode will give you answers and a roadmap to start making changes.   "There is a strong association between what we live, eat, breathe, put on our skin... and various illnesses that we're seeing." - Dr. Aly Cohen   In This Episode: - Rising rates of autoimmune disease: BPA and other chemicals - How chemicals confuse and disrupt the immune system - The Four A's of detoxification - Minerals, multivitamins, and choosing "balanced" exposure - 21-day detox plan tips and recommendations - Rethinking the food pyramid with detox at the base - Tools beyond meds to address root causes   Products & Resources Mentioned: Puori PW1 Whey Protein & Creatine+: Go to puori.com/wendy and use code WENDY to get 20% off your entire order, even on discounted subscriptions. Tru Energy Lip Peptide Treatment: Visit trytruenergy.com/wendy3 now to claim your special Buy One, Get One Free offer for a limited time. Qualia Senolytic: Get 15% off with code WENDY at https://qualialife.com/wendy. Heavy Metals Quiz: Start now at https://heavymetalsquiz.com.    About Dr. Aly Cohen Dr. Aly Cohen is a triple board-certified rheumatologist, internist, and integrative medicine physician, as well as an environmental health expert practicing in Princeton, NJ. She created and manages the environmental medicine curriculum for the Academy of Integrative Health and Medicine and is co-author of the bestselling book, Non-Toxic. Her latest book, Detoxify, connects the dots between common chemical exposures and the epidemic rise in immune disorders, offering practical, evidence-based solutions for both patients and practitioners. Learn more at alycohenmd.com    Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

In this episode of ACR Journals on Air, host Dr. Vicki Shanmugam speaks with Dr. Alain Sanchez-Rodriguez about a new study from the Lupus Midwest Network (LUMEN), published in Arthritis Care & Research. They explore how patients with systemic lupus erythematosus (SLE) experience delays and disparities in care, the types of physicians involved in diagnosis, and what the data reveals about access to specialized treatment. Dr. Sanchez-Rodriguez also shares his research journey and insights on improving equity in rheumatology. 

Cheryl and Gittel explore the importance of being mindful with our social media use. While they highlight the risks of falling into negative patterns that can lead to isolation, they also emphasize social media's powerful potential for connection and support among those living with chronic illness.Gittel shares how participating in online support communities like Rheum to THRIVE has strengthened her self-management and coping strategies. Together, Cheryl and Gittel stress the importance of setting intentional goals for social media use, fostering connection, protecting mental health, and ultimately avoiding the trap of isolation.Episode at a glance:Milestone guest return: Gittel joins the podcast for her fifth appearance and reflections on her journey with Crohn's disease and ankylosing spondylitis.Rheum To Thrive: Gittel reflects on how her relationship with the Rheum to Thrive program has grown over time.Mindful social media use: Comparing patterns of use, misuse, and abuse to drug use.The double-edged sword of social media: Exploring both its risks (isolation, negative cycles) and benefits (connection, support).Personal impact: Gittel's story of how online support communities improved her coping and self-management.Practical takeaways: Setting intentional goals for social media to foster connection, protect mental health, and avoid isolation.Medical disclaimer: All content found on Arthritis Life public channels was created for generalized informational purposes only. The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.Episode SponsorsRheum to THRIVE, an online course and support program Cheryl created to help people with rheumatic disease go from overwhelmed, confused and alone to confident, supported and connected. See all the details and join the program or waitlist now! 

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to interstitial lung diseases or experienced in respiratory care, this series offers timely insights and expert takeaways. Timestamps: 00:00: Introduction 00:40: Mainstays of treatment 04:42: Limitations of current antifibrotics 07:50: The future of ILD personalised care 13:40: Are we close to the reversal of fibrosis? 15:52: A message for clinicians

In this episode, host Saranya Ravindran is joined by Toby Maher to explore the often-overlooked world of interstitial lung diseases. From clarifying common misconceptions to highlighting AI innovations and personalised treatments, the series dives deep into what clinicians need to know about these serious lung conditions. Whether you're new to interstitial lung diseases or experienced in respiratory care, this series offers timely insights and expert takeaways. Timestamps: 00:00: Introduction 00:41: Challenges in early diagnosis 03:22: ILD biomarkers 05:49: The overlap with autoimmune diseases 09:16: AI in ILD detection

It's been over two decades since the American College of Rheumatology (ACR) last released comprehensive treatment guidelines for systemic lupus erythematosus (SLE), and much has changed. In this episode, we're joined by Dr. Lisa Sammaritano to discuss the forthcoming 2025 ACR Guidelines for the Treatment of SLE. These updated recommendations reflect a significant evolution in our approach to lupus care, from the growing range of therapeutic options to a stronger emphasis on patient engagement and minimizing steroid toxicity. We'll dive into how the guidelines tailor treatment across diverse organ systems and patient populations, and what clinicians need to know to effectively incorporate these updates into their practice. 

In this episode, Haylie Pomroy sits down with Dr. Marc Kesselman, a rheumatologist who's helped thousands navigate conditions like lupus, rheumatoid arthritis, and long COVID.  Together, they discuss why these diseases are becoming more common, the surprising ways viruses and toxins can trigger them, and what “pre-autoimmunity” testing can reveal years before symptoms even start.  Haylie also opens up about her own autoimmune journey, and why they both believe nutrition, stress management, and finding a doctor who truly listens can change the course of your health. If you've ever feared a flare, struggled to get answers, or just want to protect your immune system, this conversation will give you science, strategies, and hope you can use right now. Tune in to the Hope & Help for Fatigue and Chronic Illness Podcast - The Hidden Keys to Autoimmune Health. Enjoy our show? Please leave us a 5-star review so we can bring hope and help to others. You can also catch this show on YouTube and other podcast platforms.   Dr. Marc Kesselman is Chair of the Department of Internal Medicine at KP COM and Chief of the Division of Rheumatology. He specializes in autoimmune disease diagnosis, management, and prevention, with a focus on integrating nutrition, lifestyle, and patient communication into care.   Connect with Dr. Marc Kesselman: LinkedIn: https://www.linkedin.com/in/marc-m-kesselman-d-o-facoi-facc-facr-6491479/   Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet.   Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com   Instagram: https://www.instagram.com/hayliepomroy Facebook: https://www.facebook.com/hayliepomroy YouTube: https://www.youtube.com/@hayliepomroy/videos  LinkedIn: https://www.linkedin.com/in/hayliepomroy/  X: https://x.com/hayliepomroy    Sign up today for our newsletter. https://nova.us4.list-manage.com/subscribe?u=419072c88a85f355f15ab1257&id=5e03a4de7d   This podcast is brought to you by the Institute for Neuro-Immune Medicine. Learn more about us here. Website: https://www.nova.edu/nim/ Facebook: https://www.facebook.com/InstituteForNeuroImmuneMedicine Instagram: https://www.instagram.com/NSU_INIM/ YouTube: https://www.youtube.com/channel/UCazXfCmy5YhTrZRBh5RdfAA Twitter: https://www.twitter.com/NSU_INIM  

This episode explores the ARChiVe Registry, a longitudinal database for pediatric vasculitis, with guest Dr. Sam, a pediatric rheumatologist and bioinformatician. The discussion covers the registry's design, patient selection, and key outcomes, including remission rates, hospitalization, and damage scores (pVDI) across treatment strategies. Dr. Sam highlights how these findings inform clinical practice and discusses the challenges of observational data. The episode also touches on his unique background in social pediatrics and health informatics, emphasizing the evolving role of clinicians as both diagnosticians and data stewards in rheumatology research. 

A recent study published in The Italian Journal of Rheumatology suggests that a gluten free diet could be a promising approach to alleviating fibromyalgia pain and symptoms.Read more about the study here: https://healthnews.com/news/gluten-free-diet-fibromyalgia/?fbclid=IwAR39fWVJvsp9Ud84jGfbj7hDHIJatj3-PQgnCR4E9Zu2hoL7bpJcj5L9430I would love to hear from you! Leave your messages for Andrea at contact@baltimoreglutenfree.com and check out www.baltimoreglutenfree.comInstagramFacebookGluten Free College 101Website: www.glutenfreecollege.comFacebook: http://www.Facebook.com/Glutenfreecollege Hosted on Acast. See acast.com/privacy for more information.

In this episode, we're joined by Karen Durrant, founder of the Autoinflammatory Alliance, who shares her powerful journey from a determined parent seeking a diagnosis for her child to the leader of a global patient advocacy movement. What began as a personal quest has evolved into an international network supporting thousands affected by autoinflammatory diseases. Karen discusses how her collaboration with Dr. Fatma Dedeoglu, a leading pediatric rheumatologist, helped bridge the gap between patient experience and medical research—ultimately contributing to the development of international clinical guidelines that are transforming care for rare disease patients worldwide. 

Pediatric rheumatologist Dr. Pamela Weiss speaks with Michael and his 12 year old daughter Ava about  navigating the challenge of living with psoriasis and psoriatic arthritis together as a family.   Join moderator Kaleigh Welch as she discusses the challenges of living with psoriasis and juvenile psoriatic arthritis (JPsA) from diagnosis, misconceptions about psoriatic disease, to management and treatment with pediatric rheumatologist, Dr. Pamela Weiss from Children's Hospital of Philadelphia, Division of Rheumatology, along with Michael and Ava, whose psoriatic disease is truly a family affair. The intent of this episode is to raise awareness about the complexities and nuances associated with living with psoriasis and psoriatic arthritis as a child or an adult and not letting the disease stop you from doing what you love to do. This episode is sponsored by Amgen. Mike, Ava, and Dr. Weiss were compensated for their time. Timestamps: ·       (0:00) Intro to Psoriasis Uncovered and guest welcome pediatric rheumatologist Dr. Pamela Weiss, Michael and Ava Sayles who both have been diagnosed with psoriasis and psoriatic        arthritis.   ·       (1:28) What the psoriatic disease diagnosis process could be like for children and adults.   ·       (5:34) Misconceptions associated with psoriasis leading to delayed diagnosis of psoriatic arthritis. ·       (7:36) What people misunderstand about plaque psoriasis and psoriatic arthritis. ·       (11:06) Challenges to finding the right treatment while living life with psoriatic disease. ·       (17:24) What drives treatment choices for psoriatic disease in youth. ·       (19:59) Assessing what's most important in reaching treatment goals. ·       (23:57) What the future holds for management of Juvenile Psoriatic Arthritis (JPsA). ·       (26:10) Living with psoriatic disease is challenging but find what's right for you and don't give up on what you love to do. Key Takeaways: ·       Diagnosis of plaque psoriasis and psoriatic arthritis can be challenging given subtleties that can occur in the presentation of the disease in adults and children. ·       There are a variety of treatments that work either alone or in combination to treat plaque psoriasis and psoriatic arthritis with choice of treatment dependent on what is the primary goal for the individual's physical and emotional health. ·       The future is bright as understanding of the disease increases and treatment options expand and become more targeted to more effectively address skin and joint issues associated with psoriatic disease. Guest Bios:   Pamela Weiss, M.D., MSCE, is a pediatric rheumatologist and the Clinical Research Director of the Division of Rheumatology at Children's Hospital of Philadelphia. Dr. Weiss is also the Distinguished Endowed Chair in the Department of Pediatrics. She has advanced training in clinical epidemiology with a focus on early diagnosis, and targeted treatment of children with spondyloarthritis (SpA). Dr. Weiss is also a Professor of Pediatrics and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. She is a member of the American Academy of Pediatrics, American College of Rheumatology, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the Spondylitis Association of America, and the SPondyloArthritis Research & Treatment Network (SPARTAN). Michael and Ava Sayles, psoriatic disease is a family affair. Both father and daughter, successfully navigate living with plaque psoriasis and psoriatic arthritis. Michael or Mike was diagnosed in his twenties, and Ava at age 7 and then later on juvenile psoriatic arthritis. She is now 12 years old.  They have experienced issues with diagnosis, and a long journey of finding treatment options that worked for them. Mike found the best solution was establishing a routine or rhythm of treatment around work and school to avoid flare-up's if possible, saying “keeping on top of what you need to do for the psoriasis and the arthritis becomes a big part of your life".  Resources: Our Spot: What is Psoriatic Arthritis  

This week, we explore the potential role of sodium-glucose cotransporter-2 (SGLT2) inhibitors in patients with systemic lupus erythematosus (SLE) and comorbid type 2 diabetes (T2D)—a population historically excluded from landmark SGLT2i trials. Our guest, Dr. Karen Costenbader, discusses the rationale behind the study, the nuances of trial emulation design, and key findings regarding cardiovascular and renal outcomes, infection risk, and prescribing patterns in this complex cohort. We also unpack implications for clinical decision-making and the evolving landscape of metabolic and cardiovascular care in autoimmune disease. 

Take the ache out of those joint aches! Learn about inpatient diagnosis and management of crystalline arthropathies as well as a brief conversation about those rheumatology NOS cases. We're joined by Dr. Kimberly Trotter, MD (University of Chicago).  Claim CME for this episode at curbsiders.vcuhealth.org! Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CME Show Segments Intro Rapid fire questions/Picks of the Week Case 1 Differential Diagnosis of arthropathy Risk factors for Gout Diagnostic Evaluation  Acute Treatments  Long-term Treatments Transitions of Care for Crystalline Arthropathy Case 2 History and Physical Exam Diagnostic Work up Treatment Outro Credits Writer, Producer, Show Notes, Hosts: Meredith Trubitt MD, Monee Amin MD   Infographic, Cover Art: Caroline Coleman, MD Reviewer: Sai Achi MD, MBA, FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Kimberly Trotter, MD  Disclosures Dr. Trotter reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures.  Sponsor: Bombas Head over to Bombas.com and use code CURB for 20% off your first purchase.